Refractory neuroblastoma, victory over pain (clinical case)

  • O O Kalinchuk Vinnytsia regional pediatric clinical hospital
  • T G Korol Vinnytsia National Pirogov Memorial Medical University
  • S S Blazhko Vinnytsia regional pediatric clinical hospital
  • N U Kosechenko Vinnytsia regional pediatric clinical hospital
Keywords: neuroblastoma, children, pain syndrome, palliative treatment


Neuroblastoma is a malignant tumor that develops from the stem cells of the sympathetic ganglia and the adrenal medulla and belongs to the group of neuroendocrine tumors. It is most often localized in the adrenal glands and the retroperitoneal space, less – in sympathetic ganglia of the neck and thoracic cavity. Pain syn-drome is one of the leading manifestations in patients with disease progression. Unlike other patients, a pain syndrome in oncological patients is not a temporary or periodic sensation, it has no physio-logical expediency, it does not have a protective mechanism, but, on the contrary, pain in this group of patients leads to inadaptation, distorted perception of pain and small impulses, most importantly, accompanied by various disorders of the functions of the central nervous system in the patient’s body.


Download data is not yet available.


Кириллова ОА, Волкова ЛД, Михайлова ЕВ, Захарова ЕВ, Поляков ВГ, Казанцев АП. Клинические особенности и лучевая диагностика интрапаравертебральной нейробластомы у детей. Онкопедиатрия.2015;2 (2):121–30.

Онишко ВМ, Данькевич ОС, Красуля ОІ, Строкань АМ, Кравцова ЛК. Сучасний стан лікування хронічного больового синдрому в онкологічних хворих методом хімічного нейролізису. Актуальні проблеми клінічної та профілактичної медици-ни.2013;2(1):76–82.

Строганова АМ, Карселадзе АИ. Нейробластома: морфологическая структура, молекулярно-генетические особенности ипрогностические факторы. Успехи молекулярной онкологии.2016;1(3):32–43.

Фесенко МЄ, Похилько ВІ, Щербань ОА, Крикотенко ЛВ, Степченко ЮЛ. Випадок нейробластоми у новонародженої дитини. Вісник проблем біології імедицини.2017;1(135):211–4.

Шаманская ТВ, Бургол ММ, Качанов ДЮ, Рыбалко НА, Панкратьева ЛЛ, Сугак АБ и др. Ассоциация врожденных пороков сердца и нейробластомы удетей. Вопросы гематологии / онкологии и иммунопатологии в педиатрии. 2018;17(3):28–35.

Brodeur GM, Bagatell R. Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol.2014;11(12):704–13.

Carlson C. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. Journal of Pain Research.2016;9:515–34.

Connor SR, Bermedo MC. Global Atlas of Palliative Care at the End of Life. Geneva, Switzerland– London, UK: World Health Organization, the Worldwide Palliative Care Alliance.2014; 112 p.

Iehara T, Hiyama E, Tajiri et al. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent? Eur J Cancer.2012;48(11):1707–12.

Gustafson WC, Weiss WA. Myc proteins as therapeutic targets. Oncogene.2010;29 (9):1249–59.

Harstall C, Ospina M. How Prevalent Is Chronic Pain? Pain: Clinical Updates.2003; Vol.11, Issue 2:1–4.

Malis J. Clinical presentation of neuroblastoma. Prague: University Hospital Motol and Charles University.2013;158(1):9–14.

Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction.2012;108 (4):688–98.

Narcotic Drugs: Estimated World Requirements for 2015. Statistics for 2013: Report of the International Narcotics Control Board for 2014.New York: United Nations, 2015.466 p.

Krakauer E, Wenk R, Buitrago R et al. Opioid inaccessibility and its human consequences: reports from the field. Journal Pain and Palliative Care Pharmacotherapy.2010;24 (3):239–43.

Rocque G, Cleary J. Palliative care reduces morbidity and mortality in cancer. Nature Reviews Clinical Oncology.2013;10 (2):80–89.

Рефрактерна нейробластома, перемога над болем (клінічний випадок)
How to Cite
Kalinchuk OO, Korol TG, Blazhko SS, Kosechenko NU. Refractory neuroblastoma, victory over pain (clinical case). PMJUA [Internet]. 2019Feb.21 [cited 2019Jun.26];3(4):64-8. Available from:
Clinical thinking